Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03190174
Title Nivolumab (Opdivo) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sarcoma Oncology Research Center, LLC
Indications

chondrosarcoma

Ewing sarcoma

malignant fibrous histiocytoma

osteosarcoma

liposarcoma

Therapies

Nab-rapamycin + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.